NCT03975491Completed
The Exercise And Colorectal Cancer Treatment Trial
The Exercise And Colorectal Cancer Treatment (EXACT) Trial
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 4 Jun 2019
- Start date
- 1 Aug 2019
- Primary completion date
- 1 May 2023
- Lead sponsor
- Pennington Biomedical Research Center
- Diseases
- Colorectal cancer
- NCT number
- NCT03975491
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Aug 2019 to the primary completion date, 1 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of metastatic colon cancer
- Concurrently actively treated other cancer (except non-melanoma skin cancer or in situ cancers)
- Or any other condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise program (as determined by the investigative team)
Other
- Currently enrolled in another clinical trial of weight loss, physical activity, or dietary intervention
- Current body mass greater than or equal to 181 kg
- Unable to provide a baseline fasting blood sample
- Unable or unwilling to give informed consent
- Unable or unwilling to be randomized
Who the study is looking for
- Age ≥18 years
- Histologically-confirmed stage I-III colorectal cancer
- Completed surgical resection
- Completed chemotherapy (if applicable)
- Completed radiotherapy (if applicable)
- Provide written approval by physician or other qualified healthcare provider
- No planned major surgery during the study period (including colostomy reversal; chemotherapy infusion port removal is permitted)
- Readiness to exercise \[as determined by a modified version the Physical Activity Readiness Questionnaire (PAR-Q)
- Allow the collection and storage of specimens and data for future use
- Willing to be randomized
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pennington Biomedical Research Center Coordinator of this site? Confirm its status | Baton Rouge | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.